BioSpace Collaborative

Academic/Biomedical Research
News & Jobs
Biotechnology and Pharmaceutical Channel Medical Device and Diagnostics Channel Clinical Research Channel BioSpace Collaborative    Job Seekers:  Register | Login          Employers:  Register | Login  

NEWSLETTERS
Free Newsletters
Archive
My Subscriptions

NEWS
News by Subject
News by Disease
News by Date
PLoS
Search News
Post Your News
JoVE

CAREER NETWORK
Job Seeker Login
Most Recent Jobs
Search Jobs
Post Resume
Career Fairs
Career Resources
For Employers

HOTBEDS
Regional News
US & Canada
  Biotech Bay
  Biotech Beach
  Genetown
  Pharm Country
  BioCapital
  BioMidwest
  Bio NC
  BioForest
  Southern Pharm
  BioCanada East
  C2C Services & Suppliers™
Europe
Asia

DIVERSITY

PROFILES
Company Profiles

INTELLIGENCE
Research Store

INDUSTRY EVENTS
Research Events
Post an Event
RESOURCES
Real Estate
Business Opportunities

 News | News By Subject | News by Disease News By Date | Search News
Get Our Industry eNewsletter FREE email:    
   

Simbionix Releases Lower Limb Training Module for the ANGIO Mentor(TM) Endovascular Simulator


6/5/2012 9:49:12 AM

CLEVELAND, Ohio, June 4, 2012 /PRNewswire/ --

Simbionix USA Corporation, the world's leading provider of medical simulation, training and education products, announces increasing its library of training opportunities on the ANGIO Mentor with the new Below-The-Knee (BTK) module.

(Logo: http://photos.prnewswire.com/prnh/20120502/529202-a )

(Photo: http://photos.prnewswire.com/prnh/20120604/537351 )

The Simbionix ANGIO Mentor products are multidisciplinary surgical simulators that provide hands-on practice of endovascular procedures in a virtual reality simulated environment.

Lower-limb ischemia, a Peripheral Arterial Disease (PAD), is a vascular disorder which occurs when oxygen supply to the leg tissues is reduced due to poor blood flow caused by atherosclerosis.

Patients with Critical Limb Ischemia present with rest pain, which may progress to ulceration and gangrene, experience high amputation rates, significant morbidity and cardiovascular events. Undergoing endovascular below-the-knee revascularization may increase the possibility of saving the limb.

Still, Critical Limb Ischemia is associated with multi-segmental complex arterial lesions, which contribute to the challenge of these procedures. Developments in medical devices and recent advancement in techniques help surgeons overcome these procedural challenges. The Simbionix BTK simulation module helps surgeons build confidence with the clinical and practical aspects of BTK Interventions using the latest techniques and therapeutic approaches available.

The module was developed in collaboration with leading worldwide physicians, including Dr. Andrej Schmidt from the Center for Vascular Medicine, Parkhospital and Heartcenter Leipzig, Germany. "The role of endovascular therapy for patients with critical limb ischemia is steadily increasing. Therefore skills to treat infrapopliteal arteries is extremely important, which are clearly completely different to treat than iliac or femoropopliteal lesions. Simbionix module for BTK interventions is, in our opinion, a very important learning-tool and perfectly brought into praxis."

"The ANGIO Mentor provides a complete training solution to learners of all levels and across multiple disciplines," said Gary Zamler, Simbionix CEO. "The new BTK module was very well received by doctors of all skills levels, who all commented on the high realism of the simulated procedure in comparison to other available products. The ANGIO Mentor's true value lies within its vast training opportunities. As we strive to offer our customers the best ROI, we continuously develop new modules for this robust simulator to answer the needs of endovascular surgeons."

To experience the ANGIO Mentor hands-on, visit Simbionix at the training sessions at SVS, June 6-8, in National Harbor, MD.

About Simbionix USA Corporation

Simbionix is the world's leading provider of medical simulation training and educationproducts for medical professionals and the healthcare industry. The company is committed to delivering high quality products, advancing clinical performance and optimizing procedural outcomes.
Visit: http://www.simbionix.com Follow us on Facebook, Twitter and LinkedIn.

Contact: Rebecca Levy, Manager of Marketing Communications, rebecca@simbionix.com; +1-216-229-2040 - ext. 128


SOURCE Simbionix USA Corporation


Read at BioSpace.com

Simbionix
 
 

ADD TO DEL.ICIO.US    ADD TO DIGG    ADD TO FURL    ADD TO STUMBLEUPON    ADD TO TECHNORATI FAVORITES
 

//-->